Tatsumi Moriya

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Prevention of Transition From Incipient to Overt Nephropathy With Telmisartan in Patients With Type 2 Diabetes

Hirofumi Makino, Masakazu Haneda, Tetsuya Babazono et al. · Diabetes Care · 2007 · 226 citations

Angiotensin Ii Blocker, Hypertension, Renal Pathology +19

A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy

Masakazu Haneda, Kazunori Utsunomiya, Daisuke Koya et al. · Journal of Diabetes Investigation · 2014 · 187 citations · Full text

Glomerular Disease, Diabetic Nephropathy 2014, Glomerulonephritis +18

Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes

Takashi Wada, Masakazu Haneda, Kengo Furuichi et al. · Clinical and Experimental Nephrology · 2013 · 146 citations · Full text

All-cause Mortality, Hemodialysis, Urology +14

17 β -Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters

Takashi Suzuki, Tatsumi Moriya, Naohiro Ariga et al. · British Journal of Cancer · 2000 · 130 citations · Full text